With muscle-building treatment, mice live longer even as tumors grow
August 18, 2010 by admin · Leave a Comment
In the vast majority of patients with advanced cancer, their muscles will gradually waste away for reasons that have never been well understood. Now, researchers reporting in the August 20 issue of Cell, a Cell Press Publication, have found some new clues and a way to reverse that process in mice. What’s more, animals with cancer that received the experimental treatment lived significantly longer, even as their tumors continued to grow.
A ‘magnetic’ solution to identify and kill tumors
Tel Aviv University researcher develops nano-methods for treating cancer tumors with heat and magnets
Though a valuable weapon against cancerous tumors, radiation therapy often harms healthy tissue as it tries to kill malignant cells. Now, Prof. Israel Gannot of Tel Aviv University’s Department of Biomedical Engineering is developing a new way to destroy tumors with fewer side effects and minimal damage to surrounding tissue.
New diagnostic chip able to generate single-cell molecular ‘fingerprints’ for brain tumors
August 1, 2010 by admin · Leave a Comment
Technology marks advance toward predictive and personalized medicine
New technologies for the diagnosis of cancer are rapidly changing the clinical practice of oncology. As scientists learn more about the molecular basis of cancer, the development of new tools capable of multiple, inexpensive biomarker measurements on small samples of clinical tissue will become essential to the success of genetically informed and personalized cancer therapies.
Morphine blocks tumor growth
July 27, 2010 by admin · Leave a Comment
Minneapolis, MN Current research suggests that taking morphine can block new blood vessel and tumor growth. The related report by Koodie et al, “Morphine suppresses tumor angiogenesis through a HIF1α/p38MAPK pathway,” appears in the August 2010 issue of the American Journal of Pathology.
Researchers use nanoparticles to shrink tumors in mice
July 9, 2010 by admin · Leave a Comment
Findings hold important implications for cancer therapy
The application of nanotechnology in the field of drug delivery has attracted much attention in recent years. In cancer research, nanotechnology holds great promise for the development of targeted, localized delivery of anticancer drugs, in which only cancer cells are affected.
Tumor virus is best predictor of throat cancer survival
June 6, 2010 by admin · Leave a Comment
COLUMBUS, Ohio The presence of human papilloma virus, the virus that causes cervical cancer, in tumors is the most important predictor of survival for people diagnosed with oropharyngeal cancer (cancer of the back of the mouth), according to a new study led by a researcher at the Ohio State University Comprehensive Cancer Center-Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC-James).
Experimental targeted therapy shows early promise against medulloblastomas
June 5, 2010 by admin · Leave a Comment
(CHICAGO June 5, 2010) Researchers from St. Jude Children’s Research Hospital and the Pediatric Brain Tumor Consortium (PBTC) presented at the American Society of Clinical Oncology the findings of a pediatric brain tumor study using an experimental drug that targets the underlying genetic makeup of the tumor. The research focused on a new way to attack the tumors by blocking the Hedgehog pathway that is linked to approximately 20 percent of medulloblastomas.
Blocking tumor’s ‘death switch’ paradoxically stops tumor growth
May 25, 2010 by admin · Leave a Comment
Contact: Robert Mitchum
robert.mitchum@uchospitals.edu
773-702-6241
University of Chicago Medical Center
A new cancer vaccine starves tumors of blood
May 23, 2010 by admin · Leave a Comment
A DNA-vaccine that restricts the supply of blood to tumours has been developed by scientists at the Swedish medical university Karolinska Institutet. The vaccine slows the growth of breast cancer tumours in mice.
Genetics of children’s brain tumor unlocked
May 17, 2010 by admin · Leave a Comment
Contact: Professor Richard Grundy
richard.grundy@nottingham.ac.uk
44-115-823-0620
University of Nottingham
Researchers have identified an important cancer gene that could lead to more effective drugs being developed to fight paediatric high grade glioma, a disease which currently has a poor prognosis.
